insights_auto
Why is MBIO up 3,12%?
Dive Deeperchevron_right
MBIO:NASDAQ
Mustang Bio Inc
0,41 US$
arrow_upward
+3,12%(+0,013) 1D
12 ოქტ, 11:10:57 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MBIO...
Open
0,41 US$
High
0,44 US$
Low
0,40 US$
Mkt. cap
3,13 მლნ.
Avg. vol.
31,29 ათ.
Volume
14,86 ათ.
52-wk high
1,69 US$
52-wk low
0,38 US$
EPS
-0,46 US$
Beta
2,09
Shares outstanding
6,73 მლნ.
No. of employees
4
Open
0,41 US$
High
0,44 US$
Low
0,40 US$
Mkt. cap
3,13 მლნ.
Avg. vol.
31,29 ათ.
Volume
14,86 ათ.
52-wk high
1,69 US$
52-wk low
0,38 US$
EPS
-0,46 US$
Beta
2,09
Shares outstanding
6,73 მლნ.
No. of employees
4
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 კვირის წინ
MBIO Q4 2024 Earnings: Wider-Than-Expected Loss Per Share Dominates the Quarter - Revenue Warning Signal
Profile
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency. Wikipedia
About Mustang Bio Inc
CEOManuel Litchman
Employees4
Founded2015
HeadquartersWaltham, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
Sector-
Websitemustangbio.com